Castleview Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-62
| Closed | -$4.84K | – | 572 |
|
|
2024
Q2 | $4.84K | Buy |
62
+26
| +72% | +$2.03K | ﹤0.01% | 627 |
|
|
2024
Q1 | $2.44K | Sell |
36
-267
| -88% | -$18.1K | ﹤0.01% | 723 |
|
|
2023
Q4 | $20.4K | Hold |
303
| – | – | 0.01% | 435 |
|
|
2023
Q3 | $20.5K | Hold |
303
| – | – | 0.02% | 358 |
|
|
2023
Q2 | $21.7K | Sell |
303
-12
| -4% | -$859 | 0.02% | 347 |
|
|
2023
Q1 | $21.7K | Buy |
+315
| New | +$21.7K | 0.02% | 337 |
|
|
2022
Q4 | – | Sell |
-313
| Closed | -$17K | – | 655 |
|
|
2022
Q3 | $17K | Sell |
313
-3,287
| -91% | -$179K | 0.02% | 333 |
|
|
2022
Q2 | $11K | Buy |
3,600
+3,026
| +527% | +$9.23K | 0.01% | 447 |
|
|
2022
Q1 | $38K | Sell |
574
-2,105
| -79% | -$139K | 0.02% | 376 |
|
|
2021
Q4 | $46 | Buy |
+2,679
| New | +$46 | ﹤0.01% | 893 |
|
|
2021
Q2 | $3K | Buy |
+56
| New | +$3K | ﹤0.01% | 823 |
|